6 days ago

Trader who made $49 million shorting crypto lost $24 million on ether in 12 seco...

The Hyperliquid wallet known as pension-usdt.eth was forced out of a 50,000 ETH short as ether surged, with five liquidation order...

6 days ago

Bearish crypto bets lose record $3 billion as bitcoin tops $71,000

Traders betting against crypto lost $2.74 billion in a day, more than the short side of the October 2025 crash that remains the bi...

6 days ago

Bearish crypto bets lose record $2.7 billion as bitcoin surges toward $70,000

Traders betting against crypto lost $2.74 billion in a day, more than the short side of the October 2025 crash that remains the bi...

6 days ago

Ether jumps 18% to $2,250 as bitcoin tops $69,000 in broad crypto rally

Every major except tron posted double-digit weekly gains, with nearly $1.4 billion of short positions wiped out after the Treasury...

6 days ago

Bitcoin briefly hits $70,000 for the first time since June. Here is why

The largest crypto asset rose more than 7% on Wednesday after several catalysts sent crypto-related assets higher.

6 days ago

Bitcoin's Sharpest Rally in Five Months Flips Markets From Bearish to Coin Flip

Bitcoin's steepest daily gain since March caught traders off guard, and Myriad's pump-or-dump market swung from 70-30 odds to near...

6 days ago

Crypto Stocks Rip Higher as Strategy Jumps 12%, Coinbase Climbs 9%

Strategy, Coinbase, Circle, and BitMine are riding Bitcoin's short squeeze toward $70K—and two of them may be squeezing equity bea...

6 days ago

HYPE jumps 11% as Trump says CFTC is working to bring Hyperliquid to U.S.

During a White House meeting Wednesday, President Donald Trump said CFTC Chair Mike Selig is working to bring the perpetual future...

6 days ago

Kalshi Pushes Beyond Prediction Markets With Copper Perpetual Futures

The prediction market operator is seeking CFTC approval for a copper perpetual as it moves further into traditional derivatives ma...

6 days ago

Moderna Stock Doubles on Cancer Breakthrough: Here’s What It Means

A Phase 3 win against the standard of care sent the biotech's shares up 131% and left short sellers down $4.8 billion.